Join us for our next OBIO® Women in Health Initiative (WiHI) breakfast on March 27 featuring a candid conversation with Defne Garner, Co-Founder & VP, Finance at Ripple Therapeutics and Wendy Naimark, Co-Founder & CTO at Ripple Therapeutics, a clinical stage ophthalmology company. Defne and Wendy will share their career journeys and experiences starting a life science company, raising a $14M USD Series A and an additional $55M USD through partnerships and non-dilutive capital, and securing agreements with three leading strategics. Don’t miss this incredible opportunity to learn first-hand from two women leaders in Canada’s life sciences ecosystem.
